Steven Halper
Stock Analyst
(n/a)
# 4,647
Out of 4,655 analysts
76
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Steven Halper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $9.55 | +15.18% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $5.77 | +419.93% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $7.70 | +107.79% | 4 | Sep 14, 2023 | |
| RCM R1 RCM | Initiates: Overweight | $20 | $14.26 | +40.25% | 4 | Aug 15, 2023 | |
| AMWL American Well | Initiates: Overweight | $300 | $9.00 | +3,233.33% | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | $82 → $85 | $86.33 | -1.54% | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $48.67 | - | 7 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | $504 | $71.01 | +609.76% | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | $390 | $11.71 | +3,231.91% | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $9 → $8 | $23.46 | -65.90% | 6 | Jun 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $135 → $145 | $9.21 | +1,474.38% | 8 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $150 → $185 | $4.86 | +3,706.58% | 5 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $245 → $255 | $316.49 | -19.43% | 2 | Feb 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $345 → $400 | $260.71 | +53.43% | 2 | Feb 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $18.47 | +73.25% | 1 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $83 | $63.52 | +29.88% | 8 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $9.55
Upside: +15.18%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $5.77
Upside: +419.93%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $7.70
Upside: +107.79%
R1 RCM
Aug 15, 2023
Initiates: Overweight
Price Target: $20
Current: $14.26
Upside: +40.25%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: $300
Current: $9.00
Upside: +3,233.33%
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: $82 → $85
Current: $86.33
Upside: -1.54%
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $48.67
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: $504
Current: $71.01
Upside: +609.76%
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: $390
Current: $11.71
Upside: +3,231.91%
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: $9 → $8
Current: $23.46
Upside: -65.90%
Apr 15, 2020
Maintains: Neutral
Price Target: $135 → $145
Current: $9.21
Upside: +1,474.38%
Feb 21, 2020
Reiterates: Overweight
Price Target: $150 → $185
Current: $4.86
Upside: +3,706.58%
Feb 6, 2020
Reiterates: Overweight
Price Target: $245 → $255
Current: $316.49
Upside: -19.43%
Feb 5, 2020
Reiterates: Overweight
Price Target: $345 → $400
Current: $260.71
Upside: +53.43%
Jan 9, 2020
Initiates: Overweight
Price Target: $32
Current: $18.47
Upside: +73.25%
Dec 17, 2018
Maintains: Overweight
Price Target: $73 → $83
Current: $63.52
Upside: +29.88%